Transcure Introduces Tebra-Focused Billing Support for Podiatry Practices Battling Nail Debridement Denials

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The revenue cycle company pairs platform-specific claim rules with podiatry-trained coders to protect one of the highest-volume, most denial-prone services in foot care.

Transcure, a U.S. medical billing and revenue cycle management company, has introduced Tebra billing services built around the claim workflows practices run inside the platform. The first focus is podiatry, where routine foot care claims face strict Medicare rules and heavy denial risk. Practices on Tebra can now route claims through specialty review.

Tebra, formed from the merger of Kareo and PatientPop, is widely used by small and mid-sized independent practices. Many podiatry groups rely on it for daily charge capture. Generic claim rules inside any platform, however, rarely reflect the coverage logic Medicare applies to foot care. That gap shows up most clearly in nail debridement.

Medicare excludes routine foot care by statute unless the patient has a qualifying systemic condition, such as diabetes. Under CMS billing guidance, claims for CPT codes 11720 and 11721 based on a systemic condition generally need a Q7, Q8, or Q9 modifier. Each modifier must match class findings documented in the exam note.

Frequency limits add another layer, and those limits vary by Medicare contractor. Payment pressure has also increased in 2026. The CY 2026 Physician Fee Schedule applied a 2.5% efficiency adjustment to work values for many procedural codes. For practices billing nail care at high volume, every denied or underpaid claim now costs more.

“Nail debridement looks simple, but it is one of the easiest podiatry services to lose money on,” said Faran Ali, VP of Growth at Transcure. “One mismatched modifier or a missing systemic diagnosis turns a covered visit into a denial. We built this support so the claim is right before it leaves Tebra.”

The company’s nail debridement billing services cover class finding validation, Q modifier assignment, diagnosis sequencing, frequency tracking, and nail count checks. Certified coders review each routine foot care claim before submission. AI agents flag documentation gaps early, so providers can correct notes while the visit is still fresh.

Transcure reports a 98% first-pass clean claim rate and recovers 80% of previously denied claims for the practices it serves. The company has processed more than 2.7 million claims, with a 48-hour turnaround on claim submission. Its 1,100+ AAPC-certified billers support more than 43 EHR platforms, including Tebra, at a flat 5% of collections.

The service is available to podiatry practices nationwide, including groups across Ohio, Kentucky, and Indiana. Each practice receives a dedicated account manager who responds within two hours. A billing audit reviews 90 days of past claims to surface denied or underpaid nail debridement revenue.

About Transcure

Transcure is a U.S.-based medical billing and revenue cycle management company that works exclusively with medical practices. Its services include coding, claim submission, denial management, credentialing, and A/R recovery across many specialties. The company combines AAPC-certified billers with seven proprietary AI agents to increase collections and reduce administrative work. Learn more at transcure.net.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.85
-2.81 (-1.13%)
AAPL  340.90
-0.17 (-0.05%)
AMD  608.25
-22.38 (-3.55%)
BAC  56.21
-0.49 (-0.86%)
GOOG  338.19
-2.89 (-0.85%)
META  722.66
-29.00 (-3.86%)
MSFT  507.81
-8.36 (-1.62%)
NVDA  231.26
+6.19 (2.75%)
ORCL  133.62
-3.47 (-2.53%)
TSLA  361.09
-11.02 (-2.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.